losartan has been researched along with Innate Inflammatory Response in 73 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (2.74) | 18.2507 |
| 2000's | 17 (23.29) | 29.6817 |
| 2010's | 40 (54.79) | 24.3611 |
| 2020's | 14 (19.18) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira, MMB | 1 |
| de Araújo, AA | 1 |
| Ribeiro, SB | 1 |
| de Sales Mota, PCM | 1 |
| Marques, VB | 1 |
| da Silva Martins Rebouças, C | 1 |
| Figueiredo, JG | 1 |
| Barra, PB | 1 |
| de Castro Brito, GA | 1 |
| de Carvalho Leitão, RF | 1 |
| Guerra, GCB | 1 |
| de Medeiros, CACX | 1 |
| Askaripour, M | 1 |
| Najafipour, H | 1 |
| Saberi, S | 1 |
| Jafari, E | 1 |
| Rajabi, S | 1 |
| Saleh, N | 1 |
| Cosarderelioglu, C | 1 |
| Vajapey, R | 1 |
| Walston, J | 1 |
| Abadir, PM | 1 |
| Shelke, V | 1 |
| Dagar, N | 1 |
| Gaikwad, AB | 1 |
| Wang, FP | 1 |
| Zhang, L | 2 |
| Lyu, J | 1 |
| Liu, Y | 3 |
| Xie, YM | 1 |
| Kim, MD | 1 |
| Baumlin, N | 1 |
| Yoshida, M | 1 |
| Polineni, D | 1 |
| Salathe, SF | 1 |
| David, JK | 1 |
| Peloquin, CA | 1 |
| Wanner, A | 1 |
| Dennis, JS | 1 |
| Sailland, J | 1 |
| Whitney, P | 1 |
| Horrigan, FT | 1 |
| Sabater, JR | 1 |
| Abraham, WM | 1 |
| Salathe, M | 1 |
| Bonfield, TL | 1 |
| Lu, P | 1 |
| Liang, LW | 1 |
| Xu, AL | 1 |
| Sun, YY | 1 |
| Jiang, SJ | 1 |
| Shi, Z | 1 |
| Klein, P | 1 |
| Friedman, A | 2 |
| Hameed, MQ | 1 |
| Kaminski, RM | 1 |
| Bar-Klein, G | 1 |
| Klitgaard, H | 1 |
| Koepp, M | 1 |
| Jozwiak, S | 1 |
| Prince, DA | 2 |
| Rotenberg, A | 1 |
| Twyman, R | 1 |
| Vezzani, A | 1 |
| Wong, M | 1 |
| Löscher, W | 1 |
| AlSaad, AMS | 1 |
| Alasmari, F | 1 |
| Abuohashish, HM | 1 |
| Mohany, M | 1 |
| Ahmed, MM | 1 |
| Al-Rejaie, SS | 1 |
| Nese, M | 1 |
| Riboli, G | 1 |
| Brighetti, G | 1 |
| Sassi, V | 1 |
| Camela, E | 1 |
| Caselli, G | 1 |
| Sassaroli, S | 1 |
| Borlimi, R | 1 |
| Aucoin, M | 1 |
| Cooley, K | 1 |
| Saunders, PR | 1 |
| Carè, J | 1 |
| Anheyer, D | 1 |
| Medina, DN | 1 |
| Cardozo, V | 1 |
| Remy, D | 1 |
| Hannan, N | 1 |
| Garber, A | 1 |
| Velayos, M | 1 |
| Muñoz-Serrano, AJ | 1 |
| Estefanía-Fernández, K | 1 |
| Sarmiento Caldas, MC | 1 |
| Moratilla Lapeña, L | 1 |
| López-Santamaría, M | 1 |
| López-Gutiérrez, JC | 1 |
| Li, J | 1 |
| Zhang, J | 3 |
| Shen, S | 1 |
| Zhang, B | 2 |
| Yu, WW | 1 |
| Toyoda, H | 1 |
| Huang, DQ | 1 |
| Le, MH | 1 |
| Nguyen, MH | 1 |
| Huang, R | 1 |
| Zhu, L | 3 |
| Wang, J | 7 |
| Xue, L | 1 |
| Liu, L | 2 |
| Yan, X | 2 |
| Huang, S | 1 |
| Li, Y | 6 |
| Xu, T | 1 |
| Li, C | 3 |
| Ji, F | 1 |
| Ming, F | 1 |
| Zhao, Y | 2 |
| Cheng, J | 1 |
| Wang, Y | 4 |
| Zhao, H | 1 |
| Hong, S | 1 |
| Chen, K | 2 |
| Zhao, XA | 1 |
| Zou, L | 1 |
| Sang, D | 1 |
| Shao, H | 1 |
| Guan, X | 1 |
| Chen, X | 3 |
| Chen, Y | 4 |
| Wei, J | 1 |
| Zhu, C | 1 |
| Wu, C | 1 |
| Moore, HB | 1 |
| Barrett, CD | 1 |
| Moore, EE | 1 |
| Jhunjhunwala, R | 1 |
| McIntyre, RC | 1 |
| Moore, PK | 1 |
| Hajizadeh, N | 1 |
| Talmor, DS | 1 |
| Sauaia, A | 1 |
| Yaffe, MB | 1 |
| Liu, C | 4 |
| Lin, Y | 1 |
| Dong, Y | 1 |
| Wu, Y | 1 |
| Bao, Y | 1 |
| Yan, H | 2 |
| Ma, J | 1 |
| Fernández-Cuadros, ME | 1 |
| Albaladejo-Florín, MJ | 1 |
| Álava-Rabasa, S | 1 |
| Usandizaga-Elio, I | 1 |
| Martinez-Quintanilla Jimenez, D | 1 |
| Peña-Lora, D | 1 |
| Neira-Borrajo, I | 1 |
| López-Muñoz, MJ | 1 |
| Rodríguez-de-Cía, J | 1 |
| Pérez-Moro, OS | 1 |
| Abdallah, M | 1 |
| Alsaleh, H | 1 |
| Baradwan, A | 1 |
| Alfawares, R | 1 |
| Alobaid, A | 1 |
| Rasheed, A | 1 |
| Soliman, I | 1 |
| Wendel Garcia, PD | 1 |
| Fumeaux, T | 1 |
| Guerci, P | 1 |
| Heuberger, DM | 1 |
| Montomoli, J | 2 |
| Roche-Campo, F | 1 |
| Schuepbach, RA | 1 |
| Hilty, MP | 1 |
| Poloni, TE | 1 |
| Carlos, AF | 1 |
| Cairati, M | 1 |
| Cutaia, C | 1 |
| Medici, V | 1 |
| Marelli, E | 1 |
| Ferrari, D | 1 |
| Galli, A | 1 |
| Bognetti, P | 1 |
| Davin, A | 1 |
| Cirrincione, A | 1 |
| Ceretti, A | 1 |
| Cereda, C | 1 |
| Ceroni, M | 1 |
| Tronconi, L | 1 |
| Vitali, S | 1 |
| Guaita, A | 1 |
| Leeds, JS | 1 |
| Raviprakash, V | 1 |
| Jacques, T | 1 |
| Scanlon, N | 1 |
| Cundall, J | 1 |
| Leeds, CM | 1 |
| Riva, A | 1 |
| Gray, EH | 1 |
| Azarian, S | 1 |
| Zamalloa, A | 1 |
| McPhail, MJW | 1 |
| Vincent, RP | 1 |
| Williams, R | 1 |
| Chokshi, S | 1 |
| Patel, VC | 1 |
| Edwards, LA | 1 |
| Alqarawi, W | 1 |
| Birnie, DH | 1 |
| Golian, M | 1 |
| Nair, GM | 1 |
| Nery, PB | 1 |
| Klein, A | 1 |
| Davis, DR | 1 |
| Sadek, MM | 1 |
| Neilipovitz, D | 1 |
| Johnson, CB | 1 |
| Green, MS | 1 |
| Redpath, C | 1 |
| Miller, DC | 1 |
| Beamer, P | 1 |
| Billheimer, D | 1 |
| Subbian, V | 1 |
| Sorooshian, A | 1 |
| Campbell, BS | 1 |
| Mosier, JM | 1 |
| Novaretti, JV | 1 |
| Astur, DC | 1 |
| Cavalcante, ELB | 1 |
| Kaleka, CC | 1 |
| Amaro, JT | 1 |
| Cohen, M | 1 |
| Huang, W | 2 |
| Li, T | 1 |
| Ling, Y | 1 |
| Qian, ZP | 1 |
| Zhang, YY | 1 |
| Huang, D | 1 |
| Xu, SB | 1 |
| Liu, XH | 1 |
| Xia, L | 1 |
| Yang, Y | 3 |
| Lu, SH | 1 |
| Lu, HZ | 1 |
| Zhang, R | 2 |
| Ma, JX | 1 |
| Tang, S | 1 |
| Li, CM | 1 |
| Wan, J | 1 |
| Wang, JF | 1 |
| Ma, JQ | 1 |
| Luo, JJ | 1 |
| Chen, HY | 2 |
| Mi, SL | 1 |
| Chen, SY | 1 |
| Su, YG | 1 |
| Ge, JB | 1 |
| Milheiro, SA | 1 |
| Gonçalves, J | 1 |
| Lopes, RMRM | 1 |
| Madureira, M | 1 |
| Lobo, L | 1 |
| Lopes, A | 1 |
| Nogueira, F | 1 |
| Fontinha, D | 1 |
| Prudêncio, M | 1 |
| M Piedade, MF | 1 |
| Pinto, SN | 1 |
| Florindo, PR | 1 |
| Moreira, R | 1 |
| Castillo-Lora, J | 1 |
| Delley, MF | 1 |
| Laga, SM | 1 |
| Mayer, JM | 1 |
| Sutjarit, N | 1 |
| Thongon, N | 1 |
| Weerachayaphorn, J | 1 |
| Piyachaturawat, P | 1 |
| Suksamrarn, A | 1 |
| Suksen, K | 1 |
| Papachristou, DJ | 1 |
| Blair, HC | 1 |
| Hu, Y | 1 |
| Shen, P | 1 |
| Zeng, N | 1 |
| Wang, L | 3 |
| Yan, D | 1 |
| Cui, L | 1 |
| Yang, K | 2 |
| Zhai, C | 1 |
| Yang, M | 1 |
| Lao, X | 1 |
| Sun, J | 1 |
| Ma, N | 1 |
| Wang, S | 1 |
| Ye, W | 1 |
| Guo, P | 1 |
| Rahimi, S | 1 |
| Singh, MP | 1 |
| Gupta, J | 1 |
| Nakanishi, I | 1 |
| Ohkubo, K | 1 |
| Shoji, Y | 1 |
| Fujitaka, Y | 1 |
| Shimoda, K | 1 |
| Matsumoto, KI | 1 |
| Fukuhara, K | 1 |
| Hamada, H | 1 |
| van der Boom, T | 1 |
| Gruppen, EG | 1 |
| Lefrandt, JD | 1 |
| Connelly, MA | 1 |
| Links, TP | 1 |
| Dullaart, RPF | 1 |
| Berry, JD | 1 |
| Bedlack, R | 1 |
| Mathews, D | 1 |
| Agnese, W | 1 |
| Apple, S | 1 |
| Meloncelli, S | 1 |
| Divizia, M | 1 |
| Germani, G | 1 |
| Adefegha, SA | 1 |
| Bottari, NB | 1 |
| Leal, DB | 1 |
| de Andrade, CM | 1 |
| Schetinger, MR | 1 |
| Martínez-Velasco, A | 1 |
| Perez-Ortiz, AC | 1 |
| Antonio-Aguirre, B | 1 |
| Martínez-Villaseñor, L | 1 |
| Lira-Romero, E | 1 |
| Palacio-Pastrana, C | 1 |
| Zenteno, JC | 1 |
| Ramirez, I | 1 |
| Zepeda-Palacio, C | 1 |
| Mendoza-Velásquez, C | 1 |
| Camacho-Ordóñez, A | 1 |
| Ortiz Bibriesca, DM | 1 |
| Estrada-Mena, FJ | 1 |
| Martin, BL | 1 |
| Thompson, LC | 1 |
| Kim, YH | 2 |
| Snow, SJ | 1 |
| Schladweiler, MC | 1 |
| Phillips, P | 1 |
| Harmon, M | 1 |
| King, C | 1 |
| Richards, J | 1 |
| George, I | 1 |
| Haykal-Coates, N | 1 |
| Gilmour, MI | 1 |
| Kodavanti, UP | 1 |
| Hazari, MS | 1 |
| Farraj, AK | 1 |
| Shen, Z | 1 |
| Zou, Y | 1 |
| Gao, K | 1 |
| Lazar, S | 1 |
| Wurtzel, JGT | 1 |
| Ma, P | 1 |
| Goldfinger, LE | 1 |
| Vukelic, M | 1 |
| Laloo, A | 1 |
| Kyttaris, VC | 1 |
| Chen, R | 1 |
| Chen, J | 2 |
| Xun, J | 1 |
| Hu, Z | 1 |
| Huang, Q | 2 |
| Steinhart, C | 1 |
| Shen, Y | 1 |
| Lu, H | 1 |
| Mansuri, A | 1 |
| Lokhande, K | 1 |
| Kore, S | 1 |
| Gaikwad, S | 1 |
| Nawani, N | 1 |
| Swamy, KV | 1 |
| Junnarkar, M | 1 |
| Pawar, S | 1 |
| Shaheen, MY | 1 |
| Basudan, AM | 1 |
| Niazy, AA | 1 |
| van den Beucken, JJJP | 1 |
| Jansen, JA | 1 |
| Alghamdi, HS | 1 |
| Gao, Q | 2 |
| Guo, X | 1 |
| Cao, Y | 2 |
| Jia, X | 1 |
| Xu, S | 1 |
| Lu, C | 2 |
| Zhu, H | 2 |
| Melku, M | 1 |
| Abebe, G | 1 |
| Teketel, A | 1 |
| Asrie, F | 1 |
| Yalew, A | 1 |
| Biadgo, B | 1 |
| Kassa, E | 1 |
| Damtie, D | 1 |
| Anlay, DZ | 1 |
| Ahmed, MFE | 1 |
| Ramadan, H | 1 |
| Seinige, D | 1 |
| Kehrenberg, C | 1 |
| Abd El-Wahab, A | 1 |
| Volkmann, N | 1 |
| Kemper, N | 1 |
| Schulz, J | 1 |
| Hu, MY | 1 |
| Wu, YN | 1 |
| McEvoy, MP | 1 |
| Wang, YF | 1 |
| Cong, WL | 1 |
| Liu, LP | 1 |
| Li, XX | 1 |
| Zhou, CL | 1 |
| Chen, WM | 1 |
| Wei, KL | 1 |
| Tung, SY | 1 |
| Shen, CH | 1 |
| Chang, TS | 1 |
| Yen, CW | 1 |
| Hsieh, YY | 1 |
| Chiu, WN | 1 |
| Hu, JH | 1 |
| Lu, SN | 1 |
| Hung, CH | 1 |
| Alakavuklar, MA | 1 |
| Fuqua, C | 1 |
| Luo, KL | 1 |
| Underwood, RS | 1 |
| Greenwald, I | 1 |
| Elashiry, MM | 1 |
| Elashiry, M | 1 |
| Zeitoun, R | 1 |
| Elsayed, R | 1 |
| Tian, F | 1 |
| Saber, SE | 1 |
| Elashry, SH | 1 |
| Tay, FR | 1 |
| Cutler, CW | 1 |
| O'Dowd, A | 1 |
| Maciel, M | 1 |
| Poole, ST | 1 |
| Jobling, MG | 1 |
| Rollenhagen, JE | 1 |
| Woods, CM | 1 |
| Sincock, SA | 1 |
| McVeigh, AL | 1 |
| Gregory, MJ | 1 |
| Maves, RC | 1 |
| Prouty, MG | 1 |
| Holmes, RK | 1 |
| Savarino, SJ | 1 |
| Mor, MK | 1 |
| Palevsky, PM | 1 |
| Kaufman, JS | 1 |
| Thiessen Philbrook, H | 1 |
| Weisbord, SD | 1 |
| Parikh, CR | 1 |
| John, CM | 1 |
| Phillips, NJ | 1 |
| Jarvis, GA | 1 |
| Zhu, Y | 1 |
| Kilburn, S | 1 |
| Kapoor, M | 1 |
| Chaturvedi, S | 1 |
| Shaw, KJ | 1 |
| Chaturvedi, V | 1 |
| Kong, X | 2 |
| Zhang, T | 1 |
| Xiao, H | 1 |
| Feng, X | 1 |
| Tu, H | 1 |
| Feng, J | 1 |
| Sabet, M | 1 |
| Tarazi, Z | 1 |
| Griffith, DC | 1 |
| Nguyen, F | 1 |
| Guan, P | 1 |
| Guerrero, DT | 1 |
| Kolla, V | 1 |
| Naraparaju, K | 1 |
| Perry, LM | 1 |
| Soberman, D | 1 |
| Pressly, BB | 1 |
| Alferiev, IS | 1 |
| Chorny, M | 1 |
| Brodeur, GM | 1 |
| Gao, X | 2 |
| Cheng, YH | 1 |
| Enten, GA | 1 |
| DeSantis, AJ | 1 |
| Gaponenko, V | 1 |
| Majetschak, M | 1 |
| Kim, DY | 1 |
| Choi, MJ | 1 |
| Ko, TK | 1 |
| Lee, NH | 1 |
| Kim, OH | 1 |
| Cheon, HG | 1 |
| Cai, H | 1 |
| Yip, V | 1 |
| Lee, MV | 1 |
| Wong, S | 1 |
| Saad, O | 1 |
| Ma, S | 1 |
| Ljumanovic, N | 1 |
| Khojasteh, SC | 1 |
| Kamath, AV | 1 |
| Shen, BQ | 1 |
| Cuypers, ML | 1 |
| Chanteux, H | 1 |
| Gillent, E | 1 |
| Bonnaillie, P | 1 |
| Saunders, K | 1 |
| Beckers, C | 1 |
| Delatour, C | 1 |
| Dell'Aiera, S | 1 |
| Ungell, AL | 1 |
| Nicolaï, J | 1 |
| Knapp, AK | 1 |
| Chen, A | 1 |
| Griffin-Nolan, RJ | 1 |
| Baur, LE | 1 |
| Carroll, CJW | 1 |
| Gray, JE | 1 |
| Hoffman, AM | 1 |
| Li, X | 4 |
| Post, AK | 1 |
| Slette, IJ | 1 |
| Collins, SL | 1 |
| Luo, Y | 1 |
| Smith, MD | 1 |
| Temitayo, GI | 1 |
| Olawande, B | 1 |
| Emmanuel, YO | 1 |
| Timothy, AT | 1 |
| Kehinde, O | 1 |
| Susan, LF | 1 |
| Ezra, L | 1 |
| Joseph, OO | 1 |
| Lev, S | 1 |
| Desmarini, D | 1 |
| Liuwantara, D | 1 |
| Sorrell, TC | 1 |
| Hawthorne, WJ | 1 |
| Djordjevic, JT | 1 |
| Verso, MG | 1 |
| Costantino, C | 1 |
| Marrella, A | 1 |
| Immordino, P | 1 |
| Vitale, F | 1 |
| Amodio, E | 1 |
| Wang, YD | 1 |
| Yao, WL | 1 |
| Xin, ZM | 1 |
| Han, TT | 1 |
| Wang, ZG | 1 |
| Chen, L | 1 |
| Cai, C | 1 |
| Zhang, Y | 4 |
| Ba, D | 1 |
| Wen, S | 1 |
| Tian, Q | 1 |
| Lv, W | 1 |
| Cheng, G | 1 |
| Li, N | 1 |
| Yue, XY | 1 |
| Chu, WJ | 1 |
| Chen, Q | 1 |
| Choi, ES | 1 |
| Zhao, X | 3 |
| Zhou, HD | 1 |
| Sun, XF | 1 |
| Sharma, S | 2 |
| Chhoker, S | 1 |
| Xie, C | 1 |
| Ong, EWY | 1 |
| Tan, ZK | 1 |
| Evans, S | 1 |
| Weinheimer, CJ | 1 |
| Kovacs, A | 1 |
| Williams, JW | 1 |
| Randolph, GJ | 1 |
| Jiang, W | 1 |
| Barger, PM | 1 |
| Mann, DL | 1 |
| Liu, J | 2 |
| Huang, Y | 1 |
| Kong, L | 1 |
| Yu, X | 2 |
| Feng, B | 1 |
| Liu, D | 1 |
| Zhao, B | 1 |
| Mendes, GC | 1 |
| Yuan, P | 1 |
| Ge, D | 1 |
| Wang, WM | 1 |
| Fontes, EPB | 1 |
| Li, P | 1 |
| Shan, L | 1 |
| He, P | 1 |
| Katoh, T | 1 |
| Sengoku, T | 1 |
| Hirata, K | 1 |
| Ogata, K | 1 |
| Suga, H | 1 |
| Shun, C | 1 |
| Yong-Yi, J | 1 |
| Mei-Li, C | 1 |
| Shi-Li, L | 1 |
| Jian-Bo, Z | 1 |
| Dan-Li, W | 1 |
| Zhi-Min, G | 1 |
| Ibrahim, AM | 1 |
| Zakhary, SY | 1 |
| Amin, SAW | 1 |
| Ugurlu, M | 1 |
| Fornari, VJ | 1 |
| Hartmann, MSM | 1 |
| Vanni, JR | 1 |
| Rodriguez, R | 1 |
| Langaro, MC | 1 |
| Pelepenko, LE | 1 |
| Zaia, AA | 1 |
| Nakanjako, D | 1 |
| Zalwango, F | 1 |
| Wairagala, P | 1 |
| Luboga, F | 1 |
| Andia Biraro, I | 1 |
| Bukirwa, VD | 1 |
| Mboowa, MG | 1 |
| Cose, S | 1 |
| Seeley, J | 1 |
| Elliott, A | 1 |
| Zhao, G | 1 |
| Sun, P | 1 |
| Hao, S | 1 |
| Wang, X | 2 |
| Qu, G | 1 |
| Xing, Y | 1 |
| Xu, X | 1 |
| Maierhofer, M | 1 |
| Rieger, V | 1 |
| Mayr, T | 1 |
| Zhang, Q | 1 |
| Bigliardi, AP | 1 |
| Fernandes, CLF | 1 |
| Pinto, EA | 1 |
| Dos Santos, M | 1 |
| Garcia, EM | 1 |
| Baisch, PRM | 1 |
| Soares, MCF | 1 |
| Muccillo-Baisch, AL | 1 |
| da Silva Júnior, FMR | 1 |
| Yu, W | 1 |
| Ju, C | 1 |
| Wang, K | 1 |
| Zheng, Z | 1 |
| Liu, H | 1 |
| Gao, Y | 1 |
| Martínez-Navarro, EM | 1 |
| Cebrián-Tarancón, C | 1 |
| Moratalla-López, N | 1 |
| Lorenzo, C | 1 |
| Alonso, GL | 1 |
| Salinas, RM | 1 |
| Bermúdez de Castro, JM | 1 |
| Modesto-Mata, M | 1 |
| Martín-Francés, L | 1 |
| García-Campos, C | 1 |
| Martínez de Pinillos, M | 1 |
| Martinón-Torres, M | 1 |
| Hasani, M | 1 |
| Wu, F | 2 |
| Warriner, K | 1 |
| Kurz, M | 1 |
| Gretzke, D | 1 |
| Hörlein, R | 1 |
| Turpault, S | 1 |
| Atzrodt, J | 1 |
| Derdau, V | 1 |
| Yao, Y | 1 |
| Ou, X | 1 |
| Zhao, S | 1 |
| Tian, B | 1 |
| Jin, S | 1 |
| Jiang, Z | 1 |
| Zhou, Z | 1 |
| Liu, M | 2 |
| Jiang, GD | 1 |
| Mou, LH | 1 |
| Chen, JJ | 1 |
| Li, ZY | 1 |
| He, SG | 1 |
| Reale, E | 1 |
| Fustinoni, S | 1 |
| Mercadante, R | 1 |
| Polledri, E | 1 |
| Hopf, NB | 1 |
| Grant, PC | 1 |
| Levy, K | 1 |
| Lattimer, TA | 1 |
| Depner, RM | 1 |
| Kerr, CW | 1 |
| Sato, J | 1 |
| Merenda, MEZ | 1 |
| Uemoto, AT | 1 |
| Dos Santos, MP | 1 |
| Barion, MRL | 1 |
| Carciofi, AC | 1 |
| de Paula Dorigam, JC | 1 |
| Ribeiro, LB | 1 |
| Vasconcellos, RS | 1 |
| Waller, SB | 1 |
| Peter, CM | 1 |
| Hoffmann, JF | 1 |
| Cleff, MB | 1 |
| Faria de, RO | 1 |
| Zani, JL | 1 |
| Martins, BA | 1 |
| Sande, D | 1 |
| Solares, MD | 1 |
| Takahashi, JA | 1 |
| Yang, S | 2 |
| Jia, Y | 1 |
| Yin, C | 1 |
| Zhao, R | 1 |
| Ojha, M | 1 |
| Wu, B | 1 |
| Deepa, M | 1 |
| Mo, J | 1 |
| Au, DW | 1 |
| Wan, MT | 1 |
| Shi, J | 1 |
| Zhang, G | 1 |
| Winkler, C | 1 |
| Kong, RY | 1 |
| Seemann, F | 1 |
| Bianco, M | 1 |
| Calvano, CD | 1 |
| Ventura, G | 1 |
| Bianco, G | 1 |
| Losito, I | 1 |
| Cataldi, TRI | 1 |
| Angiolella, L | 1 |
| Staudt, A | 1 |
| Duarte, PF | 1 |
| Amaral, BPD | 1 |
| Peixoto Andrade, BCO | 1 |
| Simas, NK | 1 |
| Correa Ramos Leal, I | 1 |
| Sangenito, LS | 1 |
| Santos, ALSD | 1 |
| de Oliveira, D | 1 |
| Junges, A | 1 |
| Cansian, RL | 1 |
| Paroul, N | 1 |
| Siu, J | 1 |
| Klingler, L | 1 |
| Hung, CT | 1 |
| Jeong, SH | 1 |
| Smith, S | 1 |
| Tingle, MD | 1 |
| Wagner Mackenzie, B | 1 |
| Biswas, K | 1 |
| Douglas, RG | 1 |
| Oza, AM | 1 |
| Lorusso, D | 1 |
| Aghajanian, C | 1 |
| Oaknin, A | 1 |
| Dean, A | 1 |
| Colombo, N | 1 |
| Weberpals, JI | 1 |
| Clamp, AR | 1 |
| Scambia, G | 1 |
| Leary, A | 1 |
| Holloway, RW | 1 |
| Gancedo, MA | 1 |
| Fong, PC | 1 |
| Goh, JC | 1 |
| O'Malley, DM | 1 |
| Armstrong, DK | 1 |
| Banerjee, S | 1 |
| García-Donas, J | 1 |
| Swisher, EM | 1 |
| Cella, D | 1 |
| Meunier, J | 1 |
| Goble, S | 1 |
| Cameron, T | 1 |
| Maloney, L | 1 |
| Mörk, AC | 1 |
| Bedel, J | 1 |
| Ledermann, JA | 1 |
| Coleman, RL | 1 |
| Vlek, SL | 1 |
| Burm, R | 1 |
| Govers, TM | 1 |
| Vleugels, MPH | 1 |
| Tuynman, JB | 1 |
| Mijatovic, V | 1 |
| Leicht, AS | 1 |
| Connor, J | 1 |
| Conduit, N | 1 |
| Vaquera, A | 1 |
| Gómez, MA | 1 |
| McKay, JA | 1 |
| Church, AL | 1 |
| Rubin, N | 1 |
| Emory, TH | 1 |
| Hoven, NF | 1 |
| Kuehn-Hajder, JE | 1 |
| Nelson, MT | 1 |
| Ramanna, S | 1 |
| Auerbach, EJ | 1 |
| Moeller, S | 1 |
| Bolan, PJ | 1 |
| Fox, NP | 1 |
| Leonard, M | 1 |
| Sjerps, MJ | 1 |
| Chang, EF | 1 |
| Hyun, S | 1 |
| Saejio, A | 1 |
| Shanmugam, S | 1 |
| Liu, X | 1 |
| Sun, M | 1 |
| Bai, Z | 1 |
| Jaque-Fernandez, F | 1 |
| Beaulant, A | 1 |
| Berthier, C | 1 |
| Monteiro, L | 1 |
| Allard, B | 1 |
| Casas, M | 1 |
| Rieusset, J | 1 |
| Jacquemond, V | 1 |
| Góngora-García, OR | 1 |
| Aca-Aca, G | 1 |
| Baz-Rodríguez, SA | 1 |
| Monte, A | 1 |
| Maganaris, C | 1 |
| Baltzopoulos, V | 1 |
| Zamparo, P | 1 |
| Wang, Z | 2 |
| Hou, Y | 1 |
| Cai, L | 1 |
| Tu, YJ | 1 |
| Tan, B | 1 |
| Jiang, L | 1 |
| Wu, ZH | 1 |
| Yu, HJ | 1 |
| Li, XQ | 1 |
| Yang, AD | 1 |
| Titze, IR | 1 |
| Palaparthi, A | 1 |
| Mau, T | 1 |
| González, MA | 1 |
| Goiri, F | 1 |
| Barandika, JF | 1 |
| García-Pérez, AL | 1 |
| Jatt, LP | 1 |
| Gandhi, MM | 1 |
| Guo, R | 1 |
| Sukhija-Cohen, A | 1 |
| Bhattacharya, D | 1 |
| Tseng, CH | 1 |
| Chew, KW | 1 |
| Onwumere, J | 1 |
| Pia Tek, J | 1 |
| Budnyak, T | 1 |
| Budnyk, S | 1 |
| Karim, Z | 1 |
| Thersleff, T | 1 |
| Kuśtrowski, P | 1 |
| Mathew, AP | 1 |
| Slabon, A | 1 |
| Guo, M | 1 |
| Zhao, T | 1 |
| Xing, Z | 1 |
| Qiu, Y | 1 |
| Pan, K | 1 |
| Li, Z | 2 |
| Zhou, W | 1 |
| Ghassemi Tabrizi, S | 1 |
| Arbuznikov, AV | 1 |
| Jiménez-Hoyos, CA | 1 |
| Kaupp, M | 1 |
| Lin, MH | 2 |
| Bulman, DM | 1 |
| Remucal, CK | 1 |
| Chaplin, BP | 1 |
| Laguerre, A | 1 |
| George, LA | 1 |
| Gall, ET | 1 |
| Emerson, MS | 1 |
| Wang, H | 4 |
| Maginn, EJ | 1 |
| Margulis, CJ | 1 |
| Li, H | 2 |
| Feng, W | 1 |
| Kang, X | 2 |
| Yan, S | 1 |
| Chao, M | 1 |
| Mo, S | 1 |
| Sun, W | 1 |
| Lu, Y | 1 |
| Chen, C | 1 |
| Stevens, DM | 1 |
| Adiseshaiah, P | 1 |
| Dasa, SSK | 1 |
| Potter, TM | 1 |
| Skoczen, SL | 1 |
| Snapp, KS | 1 |
| Cedrone, E | 1 |
| Patel, N | 1 |
| Busman-Sahay, K | 1 |
| Rosen, EP | 1 |
| Sykes, C | 1 |
| Cottrell, M | 1 |
| Dobrovolskaia, MA | 1 |
| Estes, JD | 1 |
| Kashuba, ADM | 1 |
| Stern, ST | 1 |
| Özütemiz, C | 1 |
| Neil, EC | 1 |
| Tanwar, M | 1 |
| Rubin, NT | 1 |
| Ozturk, K | 1 |
| Cayci, Z | 1 |
| Duscha, BD | 1 |
| Kraus, WE | 1 |
| Jones, WS | 1 |
| Robbins, JL | 1 |
| Piner, LW | 1 |
| Huffman, KM | 1 |
| Allen, JD | 1 |
| Annex, BH | 1 |
| Mehmood, T | 1 |
| Ahmad, I | 1 |
| Bibi, S | 1 |
| Mustafa, B | 1 |
| Ali, I | 1 |
| Dahal, RH | 1 |
| Chaudhary, DK | 1 |
| Kim, DU | 1 |
| Kim, J | 2 |
| Yeter, HH | 1 |
| Gonul, I | 1 |
| Guz, G | 1 |
| Helvaci, O | 1 |
| Korucu, B | 1 |
| Akcay, OF | 1 |
| Derici, U | 1 |
| Arinsoy, T | 1 |
| Neffati, R | 1 |
| Judeinstein, P | 1 |
| Rault, J | 1 |
| Xu, Y | 1 |
| Chai, X | 1 |
| Ren, T | 1 |
| Yu, S | 1 |
| Fu, Q | 2 |
| Ye, J | 1 |
| Ge, X | 1 |
| Song, J | 1 |
| Yang, H | 5 |
| El-Baba, TJ | 1 |
| Lutomski, CA | 1 |
| Kantsadi, AL | 1 |
| Malla, TR | 1 |
| John, T | 1 |
| Mikhailov, V | 1 |
| Bolla, JR | 1 |
| Schofield, CJ | 1 |
| Zitzmann, N | 1 |
| Vakonakis, I | 1 |
| Robinson, CV | 1 |
| Langham, MC | 1 |
| Caporale, AS | 1 |
| Wehrli, FW | 1 |
| Parry, S | 1 |
| Schwartz, N | 1 |
| den Boer, RB | 1 |
| Jones, KI | 1 |
| Ash, S | 1 |
| van Boxel, GI | 1 |
| Gillies, RS | 1 |
| O'Donnell, T | 1 |
| Ruurda, JP | 1 |
| Sgromo, B | 1 |
| Silva, MA | 1 |
| Maynard, ND | 1 |
| Sivieri, EM | 1 |
| Eichenwald, EC | 1 |
| Rub, D | 1 |
| Abbasi, S | 1 |
| Krahnert, I | 1 |
| Bolze, A | 1 |
| Gibon, Y | 1 |
| Fernie, AR | 1 |
| Huang, L | 1 |
| Wan, Y | 1 |
| Dang, Z | 1 |
| Yang, P | 1 |
| Yang, Q | 2 |
| Wu, S | 3 |
| Lin, CC | 1 |
| Hsu, CT | 1 |
| Liu, W | 2 |
| Huang, SC | 1 |
| Kortz, U | 1 |
| Mougharbel, AS | 1 |
| Chen, TY | 1 |
| Hu, CW | 1 |
| Lee, JF | 1 |
| Wang, CC | 1 |
| Liao, YF | 1 |
| Li, LJ | 1 |
| Li, L | 1 |
| Peng, S | 1 |
| Stimming, U | 1 |
| Hebbar Kannur, K | 1 |
| Yaqub, TB | 1 |
| Pupier, C | 1 |
| Héau, C | 1 |
| Cavaleiro, A | 1 |
| Yamamoto, S | 2 |
| Ono, A | 1 |
| Matsui, J | 1 |
| Hoshino, N | 1 |
| Akutagawa, T | 1 |
| Miyashita, T | 1 |
| Mitsuishi, M | 1 |
| Patel, SM | 1 |
| Smith, TG | 1 |
| Morton, M | 1 |
| Stiers, KM | 1 |
| Seravalli, J | 1 |
| Mayclin, SJ | 1 |
| Edwards, TE | 1 |
| Tanner, JJ | 1 |
| Becker, DF | 1 |
| Butcher, TW | 1 |
| Yang, JL | 1 |
| Hartwig, JF | 1 |
| Yu, MF | 1 |
| Xia, ZZ | 1 |
| Yao, JC | 1 |
| Feng, Z | 1 |
| Li, DH | 1 |
| Liu, T | 1 |
| Cheng, GJ | 1 |
| He, DL | 1 |
| Li, XH | 1 |
| Huurman, R | 1 |
| Schinkel, AFL | 1 |
| de Jong, PL | 1 |
| van Slegtenhorst, MA | 1 |
| Hirsch, A | 1 |
| Michels, M | 1 |
| Kataja, A | 1 |
| Tarvasmäki, T | 1 |
| Lassus, J | 1 |
| Sionis, A | 1 |
| Mebazaa, A | 1 |
| Pulkki, K | 1 |
| Banaszewski, M | 1 |
| Carubelli, V | 1 |
| Hongisto, M | 1 |
| Jankowska, E | 1 |
| Jurkko, R | 1 |
| Jäntti, T | 1 |
| Kasztura, M | 1 |
| Parissis, J | 1 |
| Sabell, T | 1 |
| Silva-Cardoso, J | 1 |
| Spinar, J | 1 |
| Tolppanen, H | 1 |
| Harjola, VP | 1 |
| Carsetti, A | 1 |
| Damiani, E | 1 |
| Casarotta, E | 1 |
| Scorcella, C | 1 |
| Domizi, R | 1 |
| Gasparri, F | 1 |
| Gabbanelli, V | 1 |
| Pantanetti, S | 1 |
| Carozza, R | 1 |
| Adrario, E | 1 |
| Donati, A | 1 |
| Almada, E | 1 |
| Pariani, A | 1 |
| Rivabella Maknis, T | 1 |
| Hidalgo, F | 1 |
| Vena, R | 1 |
| Favre, C | 1 |
| Larocca, MC | 1 |
| Lu, ZY | 1 |
| Jiang, WD | 1 |
| Wu, P | 1 |
| Kuang, SY | 1 |
| Tang, L | 1 |
| Yang, J | 2 |
| Zhou, XQ | 1 |
| Feng, L | 1 |
| Leal, M | 1 |
| Zampini, IC | 1 |
| Mercado, MI | 1 |
| Moreno, MA | 1 |
| Simirgiotis, MJ | 1 |
| Bórquez, J | 1 |
| Ponessa, G | 1 |
| Isla, MI | 1 |
| Saliu, IO | 1 |
| Amoo, ZA | 1 |
| Khan, MF | 1 |
| Olaleye, MT | 1 |
| Rema, V | 1 |
| Akinmoladun, AC | 1 |
| Khan, AU | 1 |
| Rahman, AU | 1 |
| Yuan, Q | 1 |
| Ahmad, A | 1 |
| Khan, ZUH | 1 |
| Mahnashi, MH | 1 |
| Alyami, BA | 1 |
| Alqahtani, YS | 1 |
| Ullah, S | 1 |
| Wirman, AP | 1 |
| Gao, M | 1 |
| Deng, L | 1 |
| Zhang, K | 1 |
| Wang, M | 1 |
| Xia, Z | 1 |
| Gao, D | 1 |
| Balkissou, AD | 1 |
| Poka-Mayap, V | 1 |
| Massongo, M | 1 |
| Djenabou, A | 1 |
| Endale-Mangamba, LM | 1 |
| Olomo, EJ | 1 |
| Boulleys-Nana, JR | 1 |
| Diffo-Sonkoue, L | 1 |
| Adidigue-Ndiome, R | 1 |
| Alexandra, AJE | 1 |
| Haman-Wabi, AB | 1 |
| Adama, S | 1 |
| Iddi-Faical, A | 1 |
| Pefura-Yone, EW | 1 |
| Zhao, Q | 1 |
| Tong, W | 1 |
| Ge, C | 1 |
| Zhao, D | 1 |
| Norbäck, D | 1 |
| Li, B | 1 |
| Zhao, Z | 1 |
| Huang, C | 1 |
| Zhang, X | 2 |
| Qian, H | 1 |
| Yang, X | 1 |
| Sun, Y | 1 |
| Sundell, J | 1 |
| Deng, Q | 1 |
| Kim, HJ | 1 |
| Jeon, JW | 1 |
| Hwang, SM | 1 |
| Chu, KI | 1 |
| Cha, YH | 1 |
| Kwak, YD | 1 |
| Choi, SD | 1 |
| Aslam, M | 1 |
| Kim, CG | 1 |
| Zhou, J | 1 |
| Yang, E | 1 |
| Yang, W | 1 |
| Baker, JV | 1 |
| Wolfson, J | 1 |
| Collins, G | 1 |
| Morse, C | 1 |
| Rhame, F | 1 |
| Liappis, AP | 1 |
| Rizza, S | 1 |
| Temesgen, Z | 1 |
| Mystakelis, H | 1 |
| Deeks, S | 1 |
| Neaton, J | 1 |
| Schacker, T | 1 |
| Sereti, I | 1 |
| Tracy, RP | 2 |
| Torres, B | 1 |
| Guardo, AC | 1 |
| Squarcia, M | 1 |
| Diaz, A | 1 |
| Fabra, A | 1 |
| Caballero, M | 1 |
| Ugarte, A | 1 |
| Leal, L | 1 |
| Gatell, JM | 1 |
| Plana, M | 1 |
| Garcia, F | 1 |
| García-Martín, A | 1 |
| Navarrete, C | 1 |
| Garrido-Rodríguez, M | 1 |
| Prados, ME | 1 |
| Caprioglio, D | 1 |
| Appendino, G | 1 |
| Muñoz, E | 1 |
| Manini, TM | 2 |
| Anton, SD | 2 |
| Beavers, DP | 1 |
| Cauley, JA | 2 |
| Espeland, MA | 1 |
| Fielding, RA | 2 |
| Kritchevsky, SB | 2 |
| Leeuwenburgh, C | 1 |
| Lewis, KH | 1 |
| McDermott, MM | 2 |
| Miller, ME | 1 |
| Walston, JD | 2 |
| Radziszewska, B | 1 |
| Lu, J | 1 |
| Stowe, C | 1 |
| Newman, AB | 2 |
| Ambrosius, WT | 2 |
| Pahor, M | 2 |
| Oğuz, N | 1 |
| Kırça, M | 1 |
| Çetin, A | 1 |
| Yeşilkaya, A | 1 |
| Kim, SY | 1 |
| Senatorov, VV | 1 |
| Morrissey, CS | 1 |
| Lippmann, K | 1 |
| Vazquez, O | 1 |
| Milikovsky, DZ | 1 |
| Gu, F | 1 |
| Parada, I | 1 |
| Becker, AJ | 1 |
| Heinemann, U | 1 |
| Kaufer, D | 1 |
| Chao, Y | 1 |
| Qu, X | 1 |
| Gu, Y | 1 |
| Pu, J | 1 |
| Wu, W | 1 |
| Ye, P | 1 |
| Luo, J | 1 |
| Chen, S | 1 |
| Salmani, H | 1 |
| Hosseini, M | 1 |
| Beheshti, F | 1 |
| Baghcheghi, Y | 1 |
| Sadeghnia, HR | 2 |
| Soukhtanloo, M | 2 |
| Shafei, MN | 2 |
| Khazaei, M | 1 |
| Hosseinian, S | 1 |
| Ebrahimzadeh Bideskan, A | 1 |
| Shahraki, S | 1 |
| Samadi Noshahr, Z | 1 |
| Khajavi Rad, A | 1 |
| Lovato, L | 1 |
| Talton, J | 1 |
| Domanchuk, K | 1 |
| Kennedy, K | 1 |
| Stowe, CL | 1 |
| Walkup, M | 1 |
| Zhang, P | 1 |
| Guo, Y | 1 |
| Körner, H | 1 |
| Wu, H | 1 |
| Wei, W | 1 |
| Drews, HJ | 1 |
| Yenkoyan, K | 1 |
| Lourhmati, A | 1 |
| Buadze, M | 1 |
| Kabisch, D | 1 |
| Verleysdonk, S | 1 |
| Petschak, S | 1 |
| Beer-Hammer, S | 1 |
| Davtyan, T | 1 |
| Frey, WH | 1 |
| Gleiter, CH | 1 |
| Schwab, M | 1 |
| Danielyan, L | 1 |
| Lenart, L | 1 |
| Balogh, DB | 1 |
| Lenart, N | 1 |
| Barczi, A | 1 |
| Hosszu, A | 1 |
| Farkas, T | 1 |
| Hodrea, J | 1 |
| Szabo, AJ | 1 |
| Szigeti, K | 1 |
| Denes, A | 1 |
| Fekete, A | 1 |
| Fukutomi, M | 1 |
| Hoshide, S | 1 |
| Eguchi, K | 1 |
| Watanabe, T | 1 |
| Kario, K | 1 |
| Schwieler, JH | 1 |
| Kahan, T | 1 |
| Wallén, NH | 1 |
| Nussberger, J | 2 |
| Hjemdahl, P | 1 |
| Silveira, KD | 1 |
| Coelho, FM | 1 |
| Vieira, AT | 1 |
| Barroso, LC | 1 |
| Queiroz-Junior, CM | 1 |
| Costa, VV | 1 |
| Sousa, LF | 1 |
| Oliveira, ML | 1 |
| Bader, M | 1 |
| Silva, TA | 1 |
| Santos, RA | 1 |
| Silva, AC | 1 |
| Teixeira, MM | 1 |
| Heijnen, BF | 1 |
| Van Essen, H | 1 |
| Schalkwijk, CG | 1 |
| Janssen, BJ | 1 |
| Struijker-Boudier, HA | 1 |
| Kim, EJ | 1 |
| Song, WH | 1 |
| Lee, JU | 1 |
| Shin, MS | 1 |
| Lee, S | 1 |
| Kim, BO | 1 |
| Hong, KS | 1 |
| Han, SW | 1 |
| Park, CG | 1 |
| Seo, HS | 1 |
| Lin, CH | 1 |
| Xue, QL | 1 |
| Chuang, YF | 1 |
| Roy, CN | 1 |
| Abadir, P | 1 |
| Costa, AC | 1 |
| Romero, TR | 1 |
| Pacheco, DF | 1 |
| Perez, AC | 1 |
| Savernini, A | 1 |
| Santos, RR | 1 |
| Duarte, ID | 1 |
| Rincón, J | 2 |
| Correia, D | 1 |
| Arcaya, JL | 1 |
| Finol, E | 1 |
| Fernández, A | 1 |
| Pérez, M | 1 |
| Yaguas, K | 1 |
| Talavera, E | 1 |
| Chávez, M | 1 |
| Summer, R | 1 |
| Romero, F | 1 |
| Gong, XZ | 1 |
| Zhou, LF | 1 |
| Wang, Q | 1 |
| Tang, XC | 1 |
| Qian, YR | 1 |
| Wang, YR | 1 |
| Lu, L | 1 |
| Zhou, JJ | 1 |
| Zhong, J | 1 |
| Yancey, PG | 1 |
| Zuo, Y | 1 |
| Linton, MF | 1 |
| Fazio, S | 1 |
| Narita, I | 1 |
| Kon, V | 1 |
| Nyström, A | 1 |
| Thriene, K | 1 |
| Mittapalli, V | 1 |
| Kern, JS | 1 |
| Kiritsi, D | 1 |
| Dengjel, J | 1 |
| Bruckner-Tuderman, L | 1 |
| Goktaş, MT | 1 |
| Hatta, F | 1 |
| Karaca, O | 1 |
| Kalkisim, S | 1 |
| Kilic, L | 1 |
| Akdogan, A | 1 |
| Babaoglu, MO | 1 |
| Bozkurt, A | 1 |
| Helldén, A | 1 |
| Bertilsson, L | 1 |
| Yasar, U | 1 |
| Biancardi, VC | 1 |
| Stranahan, AM | 1 |
| Krause, EG | 1 |
| de Kloet, AD | 1 |
| Stern, JE | 1 |
| Gao, W | 1 |
| Bao, JZ | 1 |
| Liu, ZX | 1 |
| Wang, LS | 1 |
| Lu, X | 1 |
| Thunström, E | 1 |
| Manhem, K | 1 |
| Yucel-Lindberg, T | 1 |
| Rosengren, A | 1 |
| Lindberg, C | 1 |
| Peker, Y | 1 |
| Suganuma, E | 1 |
| Niimura, F | 1 |
| Matsuda, S | 1 |
| Ukawa, T | 1 |
| Nakamura, H | 1 |
| Sekine, K | 1 |
| Kato, M | 1 |
| Aiba, Y | 1 |
| Koga, Y | 1 |
| Hayashi, K | 1 |
| Takahashi, O | 1 |
| Mochizuki, H | 1 |
| Sepehri, Z | 1 |
| Masoumi, M | 1 |
| Ebrahimi, N | 1 |
| Kiani, Z | 1 |
| Nasiri, AA | 1 |
| Kohan, F | 1 |
| Sheikh Fathollahi, M | 1 |
| Kazemi Arababadi, M | 1 |
| Asadikaram, G | 1 |
| Tang, W | 1 |
| Gan, H | 1 |
| Gao, XM | 1 |
| Tsai, A | 1 |
| Al-Sharea, A | 1 |
| Su, Y | 1 |
| Moore, S | 1 |
| Han, LP | 1 |
| Kiriazis, H | 1 |
| Dart, AM | 1 |
| Murphy, AJ | 1 |
| Du, XJ | 1 |
| Abu-Taha, M | 1 |
| Rius, C | 1 |
| Hermenegildo, C | 1 |
| Noguera, I | 1 |
| Cerda-Nicolas, JM | 1 |
| Issekutz, AC | 1 |
| Jose, PJ | 2 |
| Cortijo, J | 2 |
| Morcillo, EJ | 2 |
| Sanz, MJ | 2 |
| Chehl, N | 1 |
| Gong, Q | 1 |
| Chipitsyna, G | 1 |
| Aziz, T | 1 |
| Yeo, CJ | 1 |
| Arafat, HA | 1 |
| Apostolakis, S | 1 |
| Vlata, Z | 1 |
| Vogiatzi, K | 1 |
| Krambovitis, E | 1 |
| Spandidos, DA | 1 |
| Mustonen, E | 1 |
| Säkkinen, H | 1 |
| Tokola, H | 1 |
| Isopoussu, E | 1 |
| Aro, J | 1 |
| Leskinen, H | 1 |
| Ruskoaho, H | 1 |
| Rysä, J | 1 |
| Wösten-van Asperen, RM | 1 |
| Lutter, R | 1 |
| Specht, PA | 1 |
| van Woensel, JB | 1 |
| van der Loos, CM | 1 |
| Florquin, S | 1 |
| Lachmann, B | 1 |
| Bos, AP | 1 |
| An, J | 1 |
| Nakajima, T | 1 |
| Kuba, K | 1 |
| Kimura, A | 1 |
| Nelson, CA | 1 |
| Hunter, RB | 1 |
| Quigley, LA | 1 |
| Girgenrath, S | 1 |
| Weber, WD | 1 |
| McCullough, JA | 1 |
| Dinardo, CJ | 1 |
| Keefe, KA | 1 |
| Ceci, L | 1 |
| Clayton, NP | 1 |
| McVie-Wylie, A | 1 |
| Cheng, SH | 1 |
| Leonard, JP | 1 |
| Wentworth, BM | 1 |
| Muñoz, M | 1 |
| Pedreañez, A | 1 |
| Viera, N | 1 |
| Hernández-Fonseca, JP | 1 |
| Mosquera, J | 1 |
| Yang, YP | 1 |
| Dong, QL | 1 |
| Zhang, XH | 1 |
| Zhang, YH | 1 |
| Li, SY | 1 |
| Liu, ZZ | 1 |
| Xu, H | 1 |
| Wang, N | 1 |
| Jiang, H | 1 |
| Liu, CX | 1 |
| Liu, XX | 1 |
| Dong, B | 1 |
| Merino, A | 1 |
| Alvarez-Lara, MA | 1 |
| Ramirez, R | 1 |
| Carracedo, J | 1 |
| Martin-Malo, A | 1 |
| Aljama, P | 1 |
| Toba, H | 1 |
| Tojo, C | 1 |
| Noda, K | 1 |
| Kobara, M | 1 |
| Nakata, T | 1 |
| Van Eeden, S | 1 |
| Leipsic, J | 1 |
| Paul Man, SF | 1 |
| Sin, DD | 1 |
| Kayabasi, H | 1 |
| Yilmaz, Z | 1 |
| Sit, D | 1 |
| Kadiroglu, AK | 1 |
| Yilmaz, E | 1 |
| Tsang, SW | 1 |
| Ip, SP | 1 |
| Leung, PS | 2 |
| Riaz, AA | 1 |
| Schramm, R | 1 |
| Sato, T | 1 |
| Menger, MD | 1 |
| Jeppsson, B | 1 |
| Thorlacius, H | 1 |
| Graninger, M | 1 |
| Reiter, R | 1 |
| Drucker, C | 1 |
| Minar, E | 1 |
| Jilma, B | 1 |
| Chan, LY | 1 |
| Leung, JC | 1 |
| Tang, SC | 1 |
| Choy, CB | 1 |
| Lai, KN | 1 |
| Fiebeler, A | 1 |
| Shagdarsuren, E | 1 |
| Rong, S | 1 |
| Hilfenhaus, G | 1 |
| Al-Saadi, N | 1 |
| Dechend, R | 1 |
| Wellner, M | 1 |
| Meiners, S | 1 |
| Maser-Gluth, C | 1 |
| Jeng, AY | 1 |
| Webb, RL | 1 |
| Luft, FC | 1 |
| Muller, DN | 1 |
| Sun, BK | 1 |
| Lim, SW | 1 |
| Song, JC | 1 |
| Kang, SW | 1 |
| Kim, YS | 1 |
| Kang, DH | 1 |
| Cha, JH | 1 |
| Yang, CW | 1 |
| Park, H | 1 |
| Hasegawa, G | 1 |
| Obayashi, H | 1 |
| Fujinami, A | 1 |
| Ohta, M | 1 |
| Hara, H | 1 |
| Adachi, T | 1 |
| Tamaki, S | 1 |
| Nakajima, Y | 1 |
| Kimura, F | 1 |
| Ogata, M | 1 |
| Fukui, M | 1 |
| Yoshikawa, T | 1 |
| Nakamura, N | 1 |
| Díez, J | 1 |
| Ruef, J | 1 |
| Browatzki, M | 2 |
| Pfeiffer, CA | 1 |
| Schmidt, J | 2 |
| Kranzhöfer, R | 2 |
| Chan, YC | 1 |
| Abu Nabah, YN | 1 |
| Losada, M | 1 |
| Estellés, R | 1 |
| Mateo, T | 1 |
| Company, C | 1 |
| Piqueras, L | 1 |
| Lopez-Gines, C | 1 |
| Sarau, H | 1 |
| Aksnes, TA | 1 |
| Seljeflot, I | 1 |
| Torjesen, PA | 1 |
| Höieggen, A | 1 |
| Moan, A | 1 |
| Kjeldsen, SE | 1 |
| Kübler, W | 1 |
| Blais, C | 1 |
| Leclair, P | 1 |
| Molinaro, G | 1 |
| Adam, A | 1 |
| Raghavendra, V | 1 |
| Kulkarni, SK | 1 |
| Sadoshima, J | 1 |
| Krämer, C | 1 |
| Sunkomat, J | 1 |
| Witte, J | 1 |
| Luchtefeld, M | 1 |
| Walden, M | 1 |
| Schmidt, B | 1 |
| Tsikas, D | 1 |
| Böger, RH | 1 |
| Forssmann, WG | 1 |
| Drexler, H | 1 |
| Schieffer, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial[NCT02049307] | Phase 2 | 108 participants (Actual) | Interventional | 2014-10-16 | Completed | ||
| The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study[NCT02676466] | Phase 2 | 289 participants (Actual) | Interventional | 2016-04-26 | Completed | ||
| ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA[NCT04899206] | 120 participants (Anticipated) | Observational [Patient Registry] | 2021-04-12 | Active, not recruiting | |||
| Computational Drug Repurposing for All Epidermolysis Bullosa Simplex (EBS) Cases[NCT03269474] | 60 participants (Anticipated) | Observational | 2017-11-28 | Recruiting | |||
| Phase 4 Study of Losartan in Hypertensive Men and Women With Obstructive Sleep Apnea Before and After Continuous Positive Airway Pressure (CPAP) Treatment[NCT00701428] | Phase 4 | 90 participants (Actual) | Interventional | 2008-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Change in cluster of differentiation 4 (CD4+) cell count from baseline to 12 months (NCT02049307)
Timeframe: Baseline and 12 months
| Intervention | Cells/mm^3 (Mean) |
|---|---|
| Treatment (Losartan) | 15.1 |
| Placebo | 6.8 |
Difference between treatment and control IL-6 plasma levels from pre-treatment to on-treatment values (NCT02049307)
Timeframe: Baseline and 12 months
| Intervention | pg/mL (Mean) |
|---|---|
| Treatment | 0.14 |
| Placebo | 0.29 |
Changes in the Interleukin-6 Level Between the Groups (NCT02676466)
Timeframe: Changes from baseline to month 12
| Intervention | pg/ml (Mean) |
|---|---|
| Fish Oil Active | 0 |
| Fish Oil Placebo | -0.1 |
| Losartan Active | -0.6 |
| Losartan Placebo | 3.8 |
| Fish Oil Active + Losartan Active | -0.3 |
| Fish Oil Active + Losartan Placebo | -0.2 |
| Fish Oil Placebo + Losartan Active | -1.4 |
| Fish Oil Placebo + Losartan Placebo | -1.0 |
The purpose of this test is to measure the maximum isometric strength of the hand and forearm muscles. Scoring will be taken from the best results of 3 trials. Males scores range from 88 pounds as very poor to 141 pounds as excellent with an average of 105-113 pounds. Females scores range from 44 pounds as very poor to 84 pounds as excellent with an average of 57-65 pounds. (NCT02676466)
Timeframe: 12 months
| Intervention | pounds (Mean) |
|---|---|
| Fish Oil Active | 24.8 |
| Fish Oil Placebo | 25.3 |
| Losartan Active | 25.9 |
| Losartan Placebo | 27.5 |
| Fish Oil Active + Losartan Active | 22.4 |
| Fish Oil Active + Losartan Placebo | 19.8 |
| Fish Oil Placebo + Losartan Active | 27.6 |
| Fish Oil Placebo + Losartan Placebo | 23.6 |
Frailty will be characterized with Fried criteria developed by Fried et al. that employ self-reported exhaustion, unintentional weight loss, low energy expenditure, slow gait speed, and weak grip strength. Those with >3 of the 5 factors are judged to be frail, those with 1 or 2 factors as pre-frail, and those with no factors as non-frail. (NCT02676466)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Fish Oil Active | 15 |
| Fish Oil Placebo | 3 |
| Losartan Active | 4 |
| Losartan Placebo | 1 |
| Fish Oil Active + Losartan Active | 3 |
| Fish Oil Active + Losartan Placebo | 3 |
| Fish Oil Placebo + Losartan Active | 1 |
| Fish Oil Placebo + Losartan Placebo | 1 |
The 400 meter walk test at usual pace is used to evaluate major mobility disability (MMD), defined as the inability to walk ¼ mile or 400 meters. (NCT02676466)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Fish Oil Active | 20 |
| Fish Oil Placebo | 5 |
| Losartan Active | 4 |
| Losartan Placebo | 15 |
| Fish Oil Active + Losartan Active | 4 |
| Fish Oil Active + Losartan Placebo | 3 |
| Fish Oil Placebo + Losartan Active | 7 |
| Fish Oil Placebo + Losartan Placebo | 3 |
Peak torque was measured at a rotational speed of 60 degrees per second using a commercially-available Isokinetic Dynamometer (Biodex). Torque was measured during maximal knee extension and flexion reported in Newton Meters. (NCT02676466)
Timeframe: month 12
| Intervention | Newton meters (Mean) |
|---|---|
| Fish Oil Active | 81.3 |
| Fish Oil Placebo | 77.7 |
| Losartan Active | 87.6 |
| Losartan Placebo | 78.6 |
| Fish Oil Active + Losartan Active | 85.3 |
| Fish Oil Active + Losartan Placebo | 76.6 |
| Fish Oil Placebo + Losartan Active | 84.0 |
| Fish Oil Placebo + Losartan Placebo | 86.1 |
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Range: 0-100. A lower score indicates more disability, i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. (NCT02676466)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Fish Oil Active | 41.9 |
| Fish Oil Placebo | 42.6 |
| Losartan Active | 41.8 |
| Losartan Placebo | 41.3 |
| Fish Oil Active + Losartan Active | 41.9 |
| Fish Oil Active + Losartan Placebo | 42.7 |
| Fish Oil Placebo + Losartan Active | 46.6 |
| Fish Oil Placebo + Losartan Placebo | 47.9 |
A low score on the SPPB based on 4 m walk, balance & chair stands tests is a risk factor for disability, institutionalization, morbidity and mortality in initially non-disabled older persons. The summary score and components of the SPPB have good reliability (ICCs range from 0.88 to 0.92). Higher scores are better. Range 0-12. (NCT02676466)
Timeframe: 12 months
| Intervention | units on a scale (Mean) |
|---|---|
| Fish Oil Active | 8.6 |
| Fish Oil Placebo | 8.1 |
| Losartan Active | 8.2 |
| Losartan Placebo | 8.4 |
| Fish Oil Active + Losartan Active | 8.6 |
| Fish Oil Active + Losartan Placebo | 7.3 |
| Fish Oil Placebo + Losartan Active | 8.5 |
| Fish Oil Placebo + Losartan Placebo | 9.1 |
5 reviews available for losartan and Innate Inflammatory Response
| Article | Year |
|---|---|
[Efficacy, safety, and mechanism of Huangkui Capsules in treating chronic kidney disease: Meta-analysis and integrative bioinformatics].
Topics: Capsules; Drugs, Chinese Herbal; Humans; Inflammation; Losartan; Renal Insufficiency, Chronic | 2023 |
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Topics: Acetylcysteine; Animals; Anticonvulsants; Antioxidants; Atorvastatin; Brain Injuries, Traumatic; Cef | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
The relationship between lung inflammation and cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular Diseas | 2012 |
Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Endothelium, Vascular; Fibrosis; H | 2006 |
13 trials available for losartan and Innate Inflammatory Response
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Losartan to reduce inflammation and fibrosis endpoints in HIV disease.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Fibrosis; HIV Infections | 2021 |
Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial.
Topics: Anti-HIV Agents; Fibrosis; HIV Infections; Humans; Inflammation; Losartan; Lymphoid Tissue; Raltegra | 2021 |
ENabling Reduction of Low-grade Inflammation in SEniors Pilot Study: Concept, Rationale, and Design.
Topics: Aged; Antihypertensive Agents; Double-Blind Method; Eicosapentaenoic Acid; Female; Humans; Inflammat | 2017 |
The Enabling Reduction of Low-Grade Inflammation in Seniors (ENRGISE) Pilot Study: Screening Methods and Recruitment Results.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Fatty Acids, Omega-3; Feasibility Studies; Female; H | 2019 |
Low-grade inflammation and ambulatory blood pressure response to antihypertensive treatment: the ALPHABET study.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Res | 2013 |
Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation | 2013 |
Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; C | 2014 |
[Effect of Chuanhuang No. 1 recipe on renal function and micro-inflammation in phase 3 chronic kidney disease patients].
Topics: Adult; Blood Urea Nitrogen; C-Reactive Protein; Drugs, Chinese Herbal; Female; Humans; Inflammation; | 2015 |
Neuroendocrine and Inflammatory Responses to Losartan and Continuous Positive Airway Pressure in Patients with Hypertension and Obstructive Sleep Apnea. A Randomized Controlled Trial.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Case-Control Studies; Continuous Positive Airw | 2016 |
Angiotensin receptor blockade decreases markers of vascular inflammation.
Topics: Angiotensin Receptor Antagonists; Blood Pressure; Cholesterol; Double-Blind Method; E-Selectin; Enal | 2004 |
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity.
Topics: Adipokines; Aged; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Cross-Over Studies; Double-Bl | 2007 |
Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arachidonic Acid; Biotransformation; Cells, Cultur | 2002 |
56 other studies available for losartan and Innate Inflammatory Response
| Article | Year |
|---|---|
Losartan improves intestinal mucositis induced by 5-fluorouracil in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antimetabolites, Antineoplastic; Cytokines; Female | 2021 |
Daidzein Mitigates Oxidative Stress and Inflammation in the Injured Kidney of Ovariectomized Rats: AT1 and Mas Receptor Functions.
Topics: Aged; Animals; Antioxidants; Female; Fibrosis; Humans; Inflammation; Isoflavones; Kidney; Losartan; | 2022 |
Losartan Mitigates Oxidative Stress in the Brains of Aged and Inflamed IL-10-/- Mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Brain; Disease Models, Animal; Frailty; Inflammati | 2022 |
Phloretin as an add-on therapy to losartan attenuates diabetes-induced AKI in rats: A potential therapeutic approach targeting TLR4-induced inflammation.
Topics: Acute Kidney Injury; Animals; Diabetes Mellitus, Experimental; Hypoxia; Inflammation; Kidney; Losart | 2023 |
Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Bronchi; Cells, Cultured; Cystic Fibrosis; Disease | 2020 |
Preclinical Modeling for Therapeutic Development in Cystic Fibrosis.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Inflammation; Losartan | 2020 |
Pro-inflammatory cytokines in the paraventricular nucleus mediate the adipose afferent reflex in rats.
Topics: Adipose Tissue, White; Angiotensin II; Animals; Blood Pressure; Cytokines; Heart; Inflammation; Inte | 2020 |
Renin angiotensin system blockage by losartan neutralize hypercholesterolemia-induced inflammatory and oxidative injuries.
Topics: Animals; Antihypertensive Agents; Cholesterol, Dietary; Hypercholesterolemia; Inflammation; Losartan | 2020 |
EHP-101 alleviates angiotensin II-induced fibrosis and inflammation in mice.
Topics: Administration, Oral; Angiotensin II; Animals; Anti-Inflammatory Agents; Cannabidiol; Fibroblasts; F | 2021 |
Effect of uric acid on inflammatory COX-2 and ROS pathways in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Cyclooxygenase 2; Disease Models, Animal; Humans; Hypertension; Inflammatio | 2017 |
TGFβ signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults.
Topics: Astrocytes; Blood-Brain Barrier; Brain Injuries, Traumatic; Cerebral Cortex; Computational Biology; | 2017 |
Inhibition of angiotension II type 1 receptor reduced human endothelial inflammation induced by low shear stress.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cells, Cultured; Endothelium, Vascular; Human Umbi | 2017 |
Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Behavior, Animal; Brain Diseases; Inflammation; Li | 2018 |
Nigella sativa extract is a potent therapeutic agent for renal inflammation, apoptosis, and oxidative stress in a rat model of unilateral ureteral obstruction.
Topics: Angiotensin II; Animals; Apoptosis; Captopril; Chemokine CCL2; Creatinine; Fibrosis; Inflammation; K | 2018 |
Losartan suppresses the inflammatory response in collagen-induced arthritis by inhibiting the MAPK and NF-κB pathways in B and T cells.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; B-Lymphocytes; Collagen; Cytokines; Female; | 2019 |
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats.
Topics: Administration, Intranasal; Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Animals; | 2019 |
Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Behavior, Animal; | 2019 |
Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents, Non-Stero | 2013 |
Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats.
Topics: Adaptive Immunity; Angiotensin II Type 1 Receptor Blockers; Animals; Antigens, CD; Antigens, Differe | 2014 |
Losartan improves measures of activity, inflammation, and oxidative stress in older mice.
Topics: Age Factors; Aging; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Catalase; Disease | 2014 |
Participation of AT1 and Mas receptors in the modulation of inflammatory pain.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Inflammation; Losartan; Male; Mice | 2014 |
Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Hypertension; Inflammation; Interl | 2015 |
Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.
Topics: Angiotensin Receptor Antagonists; Animals; Aortic Diseases; Apolipoproteins E; Apoptosis; Atheroscle | 2015 |
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms.
Topics: Animals; Disease Models, Animal; Epidermolysis Bullosa Dystrophica; Immunologic Factors; Inflammatio | 2015 |
Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?
Topics: Adult; Aged; Alleles; Behcet Syndrome; Chromatography, High Pressure Liquid; Colchicine; Cytochrome | 2015 |
Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Bacterial Agents; Immunity, I | 2016 |
Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway.
Topics: Adipocytes; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cells, Cultured; Inflammation; | 2016 |
Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Cell Wall; Chemokine CCL2; Disease Models | 2017 |
Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.
Topics: Antihypertensive Agents; Atorvastatin; Captopril; Coronary Artery Disease; Humans; Hydroxymethylglut | 2016 |
Renin-angiotensin system activation accelerates atherosclerosis in experimental renal failure by promoting endoplasmic reticulum stress-related inflammation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Atherosclerosis; Biomarkers; Ce | 2017 |
Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anima | 2017 |
Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Animals; Benzazepines; Case-Control Studies; Cell Ad | 2009 |
Angiotensin II regulates the expression of monocyte chemoattractant protein-1 in pancreatic cancer cells.
Topics: Adenocarcinoma; Angiotensin II; Blotting, Western; Cell Line, Tumor; Chemokine CCL2; Extracellular S | 2009 |
Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesis.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Cell Adhesi | 2010 |
Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis Regulatory Proteins; Cel | 2010 |
Ventilator-induced inflammatory response in lipopolysaccharide-exposed rat lung is mediated by angiotensin-converting enzyme.
Topics: Animals; Bronchoalveolar Lavage Fluid; Captopril; Chemokine CXCL2; Inflammation; Interleukin-10; Int | 2010 |
Losartan inhibits LPS-induced inflammatory signaling through a PPARgamma-dependent mechanism in human THP-1 macrophages.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Atherosclerosis; Cell Line | 2010 |
Inhibiting TGF-β activity improves respiratory function in mdx mice.
Topics: Animals; Biomarkers; Body Weight; Cell Adhesion Molecules; Creatine Kinase; Diaphragm; Dose-Response | 2011 |
Proinflammatory role of angiotensin II in a rat nephrosis model induced by adriamycin.
Topics: Angiotensin II; Animals; Cholesterol; Disease Models, Animal; Doxorubicin; Endothelin-1; Fluorescent | 2011 |
Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbits.
Topics: Animals; Atherosclerosis; Chemokine CCL2; Cholesterol; Drug Synergism; Fatty Acids, Monounsaturated; | 2011 |
Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients.
Topics: Antihypertensive Agents; Case-Control Studies; Cell Differentiation; Cells, Cultured; Female; Flow C | 2012 |
Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Aorta; Benzimidazoles; Be | 2012 |
The effects of Losartan on oxidative stress and inflammation in non-diabetic patients undergoing chronic hemodialysis.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; C-Reactive Protein; Female; Humans; Inflammati | 2013 |
Prophylactic and therapeutic treatments with AT 1 and AT 2 receptor antagonists and their effects on changes in the severity of pancreatitis.
Topics: alpha-Amylases; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; An | 2004 |
Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon.
Topics: Allopurinol; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Capillaries; Captopr | 2004 |
Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
Topics: Angiotensin II; Apoptosis; Cells, Cultured; Culture Media, Conditioned; Dose-Response Relationship, | 2005 |
Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Angiotensin II; Angiotensinogen; Animals; Animals, Genet | 2005 |
Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy.
Topics: Animals; C-Reactive Protein; Cyclosporine; Disease Models, Animal; Fibrosis; Inflammation; Kidney; K | 2005 |
Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertension.
Topics: Anti-Inflammatory Agents; Biomarkers; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Infla | 2006 |
Angiotensin II promotes the inflammatory response to CD40 ligation via TRAF-2.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; CD40 Antigens; CD40 Ligand | 2007 |
Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Inflammatio | 2007 |
CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cell Adhesion; Ce | 2007 |
Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Binding, Competitive; Cell Separ | 1999 |
Absence of effect of chronic angiotensin II type 1 receptor blockade on endogenous kinin concentrations-induced paw edema model in the rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Carrageenan; Dos | 1999 |
AT1 receptor antagonism enhances angiotensin-II-facilitated carrageenan-induced paw edema.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; | 2000 |
Novel AT(1) receptor-independent functions of losartan.
Topics: Angiotensin Receptor Antagonists; Anti-Inflammatory Agents; Antihypertensive Agents; Biotransformati | 2002 |